Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-evaluating Intra-Islet Paracrine Signaling: Precision, Pulsatility and the Path toward Mechanistic Clarity.

Journal of biomedical research & environmental sciences·2026
Same author

Post-Inhibitory Rebound by δ-Cells Converts Inhibition into Excitation and Confers Islet Plasticity.

bioRxiv : the preprint server for biology·2026
Same author

An optimized protocol for efficient derivation of pancreatic islets from multiple human pluripotent stem cell lines.

Stem cell reports·2026
Same author

Paracrine inhibition via G protein inwardly rectifying potassium channels regulates glucagon secretion from human pancreatic alpha cells.

Cell reports·2026
Same author

Activating Muscarinic Receptor Signaling in Intrapancreatic Neurons Is Required for Parasympathetic Cholinergic Control of Pancreatic Cell Function.

Diabetes·2026
Same author

Stable intracranial imaging of dura mater-engrafted pancreatic islet cells in awake mice.

Nature communications·2025

Related Experiment Video

Updated: Mar 25, 2026

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
11:24

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

5.9K

Liraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model.

Midhat H Abdulreda1, Rayner Rodriguez-Diaz2, Alejandro Caicedo2

  • 1Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 NW 10th Avenue, Miami, FL 33136, USA.

Cell Metabolism
|February 16, 2016
PubMed
Summary

Long-term use of incretin mimetics like liraglutide may impair insulin release and glucose control in type 2 diabetes patients. This study highlights potential risks of chronic potentiation of beta cell function.

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

10.1K
Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
07:44

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Published on: August 7, 2015

17.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
11:24

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

5.9K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

10.1K
Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
07:44

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Published on: August 7, 2015

17.1K

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Incretin mimetics are widely used for type 2 diabetes, enhancing glucose-dependent insulin secretion.
  • While short-term benefits are documented, long-term effects on pancreatic beta cell function remain unclear.

Purpose of the Study:

  • To investigate the long-term impact of liraglutide, an incretin mimetic, on human pancreatic islet and beta cell function in vivo.
  • To assess the consequences of prolonged incretin mimetic therapy on glucose homeostasis.

Main Methods:

  • Human pancreatic islets were transplanted into humanized mice.
  • Mice received daily liraglutide treatment for over 200 days.
  • Insulin release and glucose homeostasis were evaluated.

Main Results:

  • Prolonged liraglutide treatment led to compromised human insulin release from transplanted islets.
  • Deranged overall glucose homeostasis was observed in treated mice.
  • These effects suggest potential adverse outcomes with chronic incretin mimetic use.

Conclusions:

  • Long-term incretin mimetic therapy, exemplified by liraglutide, may negatively impact beta cell function and glucose regulation.
  • These findings raise concerns regarding the safety of chronic potentiation of beta cell function in type 2 diabetes management.